Kaster TS

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

5 papers · ORCID

ArticleKetamine

Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis.

Shim SR, Jeong HS, Bommersbach TJ +7

Europe PMC2026
ArticlePsychedelics

Hospital-based care for hallucinogens and risk of mania and bipolar disorder: A population-based cohort study.

Myran DT, MacDonald-Spracklin R, Pugliese M +4

Europe PMC2025
ArticleKetamine

Efficacy of intranasal esketamine versus rTMS for treatment-resistant depression: analysis of individual participant data from two clinical trials.

Kaster TS, Dai Y, Vila-Rodriguez F +4

Europe PMC2025
ArticlePsychedelics

Mortality risk among people receiving acute hospital care for hallucinogen use compared with the general population.

Myran DT, Xiao J, Fabiano N +8

Europe PMC2025
ArticlePsychedelics

Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder.

Myran DT, Pugliese M, Xiao J +9

Europe PMC2025